SEC Form 4 research
| Issuer | Voyager Therapeutics, Inc. |
|---|---|
| Tickers | VYGR |
| Reporting owners | 41 |
| Officers and directors | 18 |
| Last public filing | 2026-11-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-11-01 | Carter Todd Alfred | A | 33,000 | $0 | Not reported |
| 2026-11-03 | 2026-11-01 | Carter Todd Alfred | A | 154,000 | $0 | Not reported |
| 2026-11-03 | 2026-11-01 | Swartz Robin | A | 68,250 | $0 | Not reported |
| 2026-11-03 | 2026-11-01 | Swartz Robin | A | 318,500 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.